Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam
We report an outbreak of KPC-producing Pseudomonas aeruginosa in Spain, involving four patients and an environmental isolate recovered from a hospital sink. All isolates belonged to clone ST253 and exhibited difficult-to-treat resistance, including resistance to imipenem/relebactam and meropenem/vab...
| Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Publication Date: | 2026 |
| Country: | España |
| Institution: | Conselleria de Salut i Consum del Govern de les Illes Balears |
| Repository: | Docusalut |
| Language: | English |
| OAI Identifier: | oai:dnet:docusalut___::8a27e4da9cd6e91bc52bab090a57745d |
| Online Access: | https://hdl.handle.net/20.500.13003/27139 |
| Access Level: | Open access |
| Keyword: | KPC Pseudomonas aeruginosa carbapenem carbapenemase imipenem/relebactam meropenem/vaborbactam mutational mechanisms β-lactam resistance β-lactamase β-lactamase inhibitor |
| Summary: | We report an outbreak of KPC-producing Pseudomonas aeruginosa in Spain, involving four patients and an environmental isolate recovered from a hospital sink. All isolates belonged to clone ST253 and exhibited difficult-to-treat resistance, including resistance to imipenem/relebactam and meropenem/vaborbactam. Genomic analysis confirmed a plasmid-encoded bla KPC-2 and OprD deficiency. Functional assays demonstrated synergy between KPC-2 production and porin loss on resistance to carbapenem/β-lactamase inhibitors. The findings highlight the clinical threat posed by KPC-producing P. aeruginosa . |
|---|